UPDATE : Monday, September 7, 2020
상단여백
‘Quarter of drugs winning fast-track approvals not supplied at all’
A quarter of drugs, which have received fast-track marketing licenses for t...
by Lee Hye-seon  |  2017-10-17 16:34
라인
TissueGene promotes cell gene therapy Invossa ahead of IPO
TissueGene, the U.S.-based biopharmaceutical firm held mostly by Korea’s Ko...
by Lee Hye-seon  |  2017-10-17 14:32
라인
Mandatory drug labeling of all ingredients to start in December
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association on Friday...
by Lee Hye-seon  |  2017-10-16 15:33
라인
2 orphan drugs find manufacturers in Korea
Two orphan drugs, Dapsone and Mexiletine, which have been in supply shortag...
by Lee Hye-seon  |  2017-10-12 15:48
라인
Boryung to sell antihypertensive drugs in SE Asia
South Korea’s Boryung Pharmaceutical said it would sell its antihypertensiv...
by Lee Hye-seon  |  2017-10-11 16:02
라인
Samsung Bioepis teams up with Yuhan for biosimilars
Samsung Bioepis, which recently terminated its biosimilar sales deal with t...
by Lee Hye-seon  |  2017-10-11 14:25
라인
Anticorruption law changes drugmakers, salespersons
The Act on Prohibiting Improper Solicitation and Graft has brought about en...
by Lee Hye-seon  |  2017-09-28 17:14
라인
Korean combos, incrementally modified drugs to get insurance benefits
Korean combination drugs for hypertension, diabetes, and hyperlipidemia, an...
by Lee Hye-seon  |  2017-09-27 11:29
라인
72 drugs should warn against autoimmunity muscle disease
The approval conditions of 72 combined drugs of atorvastatin and amlodipine...
by Lee Hye-seon  |  2017-09-25 15:30
라인
Chong Kun Dang, Daewoong continue to fight over Gliatilin reference listed drug
Chong Kun Dang Pharmaceutical and Daewoong Pharm are continuing war of nerv...
by Lee Hye-seon  |  2017-09-22 12:17
라인
Samsung Bioepis gets additional approval for its biosimilar
Amid the controversy caused by MSD Korea’s alleged decision to cease promot...
by Lee Hye-seon  |  2017-09-21 12:03
라인
Big data behind CJ’s development of new drug
Has the big data at Health Insurance Review & Assessment Service (HIRA) inf...
by Lee Hye-seon  |  2017-09-20 12:05
라인
Prices of Viread's modified drugs plunge over past month
The domestic pharmaceutical companies’ plans to release the salt-altering p...
by Lee Hye-seon  |  2017-09-19 17:22
라인
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
South Korean pharmaceutical firms are seeking ways to develop combination d...
by Lee Hye-seon  |  2017-09-18 11:26
라인
Kolon uses Invossa to attract foreign patients
Kolon Life Science said it made a strategic MOU with Korea Tour Promotion A...
by Lee Hye-seon  |  2017-09-15 17:49
라인
SK Chemicals’ release of test result abroad raises curiosity
SK Chemicals has released the results of its clinical trials of the overact...
by Lee Hye-seon  |  2017-09-15 17:39
라인
Hanmi releases research result of new bio drug in Europe
Hanmi Pharmaceutical released the results of two new bio drugs the company ...
by Lee Hye-seon  |  2017-09-15 14:32
라인
LG Chem promotes antidiabetic Zemiglo in Europe
LG Chemical has launched a symposium to promote its antidiabetics drug Zemi...
by Lee Hye-seon  |  2017-09-15 11:51
라인
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon  |  2017-09-14 17:53
라인
Severance Hospital revamps emergency care center
The nation’s large-sized hospitals chronically suffer overcrowding at their...
by Lee Hye-seon  |  2017-09-13 16:08
-이전1112131415-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top